Bridgeway Capital Management, LLC Rani Therapeutics Holdings, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 56,500 shares of RANI stock, worth $93,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,500
Previous 71,500
20.98%
Holding current value
$93,790
Previous $154,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.18 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$819,3490.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$744,4960.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$502,5530.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$483,6920.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $40.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...